Global Pharma M&A Shifts: Mid-Market Deals, Regional Opportunity & Regulatory Risks
FounderNest data on 1,489 pharma M&A deals (~...
Deal value rebounded in Q1 2025 to US$37.7B (...
Large pharma is favoring mid-sized bolt-on ac...
Pricing, tariff, regulatory, and cross-border...
Deal value rebounded in Q1 2025 to US$37.7B (...
Large pharma is favoring mid-sized bolt-on ac...
Pricing, tariff, regulatory, and cross-border...










